Cefera S 500mg/250mg Injection
Marketer
Shreya Life Sciences Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Cefera S 500mg/250mg Injection
Cefixime and Sulbactam 500mg/250mg Injection is a dual-action antibiotic. It's indicated for a range of bacterial infections, inhibiting microbial growth and halting infection spread. Administration must be strictly under a doctor's guidance; adhere to the prescribed dosage schedule. Complete the entire treatment course, even with symptom improvement, as premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms to your physician promptly. Seek immediate medical attention for allergic reactions such as rash, itching, swelling, or respiratory distress. Inform your doctor of all other medications, including those for pre-existing conditions, before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While it usually doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are vital for optimal recovery. Your doctor might order blood tests and other assessments to monitor treatment response.
Primary Ingredients of Cefera S 500mg/250mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Cefera S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Cefera S 500mg/250mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cefera S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefera S 500mg/250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cefera S 500mg/250mg Injection works:
Ceftriaxone/Sulbactam 500mg/250mg Injection (Cefera S) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism of action disrupts bacterial cell wall synthesis, hindering their ability to survive. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Cefera S 500mg/250mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefera S 500mg/250mg Injection is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
Administering Cefera S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Cefera S 500mg/250mg Injection can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data on Cefera S 500mg/250mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The 500mg/250mg Cefera S Injection requires careful administration for individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage changes for the 500mg/250mg Cefera S Injection are unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Cefera S 500mg/250mg Injection :
Should you omit a scheduled dose of Cefera S 500mg/250mg Injection, seek advice from your physician.
Facts to Know About Cefera S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Infective Agents |
3,018 People bought this recently